您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Labetalol HCl
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Labetalol HCl
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Labetalol HCl图片
CAS NO:32780-64-6
包装与价格:
包装价格(元)
10mM (in 1mL DMSO)电议
100mg电议
200mg电议

产品介绍

化学性质

Physical AppearanceA solid
StorageStore at -20°C
M.Wt364.87
Cas No.32780-64-6
FormulaC19H25ClN2O3
Solubilityinsoluble in H2O; ≥18.24 mg/mL in DMSO; ≥2.98 mg/mL in EtOH with gentle warming and ultrasonic
Chemical Name2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide;hydrochloride
Canonical SMILESCC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O.Cl
运输条件蓝冰运输或根据您的需求运输。
一般建议为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。

资料参考

Labetalol HCl is a selective antagonist for the α1-adrenergic receptor and a non-selective antagonist for the β-adrenergic receptor. Labetalol HCl has been used for the treatment of high blood pressure. Labetalol HCl competitively targets the α1-adrenergic receptors expressed in vascular smooth muscle, thus inhibiting adrenergic stimulation on endothelial cells and vasoconstriction in peripheral blood vessels. Labetalol HCl also blocks the β-adrenergic receptors in bronchial and vascular smooth muscle to counteract adrenergic stimulation. Ultimately, labetalol HCl causes decreases in resting and exercise heart rates, cardiac output, as well as in both systolic and diastolic blood pressure, exherting vasodilation, as well as negative chronotropic and inotropic cardiac effects.

References:

1. National Center for Biotechnology Information (2021). PubChem Compound Summary for CID 3869, Labetalol. Retrieved August 21, 2021.

2. Dage RC, Hsieh CP. Direct vasodilatation by labetalol in anaesthetized dogs. British Journal of Pharmacology, 1980, 70(2): 287-293.

试验操作

Animal experiment:[2]

Animal models

Anaesthetized dogs

Dosage form

0.03 ~ 1 mg/kg

Given intravenously and into the vertebral artery

Applications

Labetalol HCl did not cause any immediate (5 min) change in blood pressure or heart rate when given by either route. When the cumulative dose of labetalol HCl reached 2.86 mg/kg, blood pressure fell significantly. In addition, intravenous administration of 0.03 mg/kg labetalol HCl was enough to increase heart rate at its first dose.

Note

The technical data provided above is for reference only.

References:

1. National Center for Biotechnology Information (2021). PubChem Compound Summary for CID 3869, Labetalol. Retrieved August 21, 2021.

2. Dage RC, Hsieh CP. Direct vasodilatation by labetalol in anaesthetized dogs. British Journal of Pharmacology, 1980, 70(2): 287-293.